Eotaxins and CCR3 Receptor in Inflammatory and Allergic Skin Diseases: Therapeutical Implications

E-ISSN： 1875-5933|2|1|81-94

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.2, Iss.1, 2003-03, pp. : 81-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Stress in Allergic and Inflammatory Skin Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 4, 2005-08 ,pp. : 517-519

Bentham Science Publishers

Access to resources Recommend Favorite

Keratinocytes in Inflammatory Skin Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 329-334

Bentham Science Publishers

Access to resources Recommend Favorite

CCL27, CCR10: therapeutic targets in inflammatory skin disease?

Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1089-1096

Bentham Science Publishers

Access to resources Recommend Favorite

Mast Cells in Allergic and Inflammatory Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 16, 2012-06 ,pp. : 2261-2277

Bentham Science Publishers

Access to resources Recommend Favorite